Microba Life Sciences Limited’s (MAP) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Microba Life Sciences Limited is a Sell.

Microba Life Sciences Limited’s (MAP) 20-Day exponential moving average is 0.23, while Microba Life Sciences Limited’s (MAP) share price is AU$0.25, making it a Buy.

Microba Life Sciences Limited’s (MAP) 50-Day exponential moving average is 0.20, while Microba Life Sciences Limited’s (MAP) share price is AU$0.25, making it a Buy.

Microba Life Sciences Limited (MAP) Pivot Points

Jan 19, 2025, 04:15 AM

Classic

0.23

0.24

0.25

0.26

0.27

Fibonacci

0.24

0.25

0.26

0.27

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Microba Life Sciences Limited (MAP) Moving Averages

Jan 19, 2025, 04:15 AM

MA5

0.25Sell

MA10

0.26Sell

0.25Buy

MA20

0.23Buy

MA50

0.19Buy

0.20Buy

MA100

0.18Buy

0.19Buy

MA200

0.18Buy

0.19Buy

Microba Life Sciences Limited’s (MAP) 10-Day exponential moving average is 0.25, while Microba Life Sciences Limited’s (MAP) share price is AU$0.25, making it a Buy.

Microba Life Sciences Limited’s (MAP) 100-Day exponential moving average is 0.19, while Microba Life Sciences Limited’s (MAP) share price is AU$0.25, making it a Buy.

Microba Life Sciences Limited’s (MAP) stock price is AU$0.25 and Microba Life Sciences Limited’s (MAP) 50-day simple moving average is 0.19, creating a Buy signal.

Microba Life Sciences Limited’s (MAP) stock price is AU$0.25 and Microba Life Sciences Limited’s (MAP) 100-day simple moving average is 0.18, creating a Buy signal.

Microba Life Sciences Limited’s (MAP) stock price is AU$0.25 and Microba Life Sciences Limited’s (MAP) 200-day simple moving average is 0.18, creating a Buy signal.

Microba Life Sciences Limited (MAP) Technical Indicators

Jan 19, 2025, 04:15 AM

RSI (14)

65.94

Neutral

STOCH (9,6)

41.02

Neutral

STOCHRSI (14)

60.63

Neutral

MACD (12,26)

0.02

Sell

ADX (14)

45.45

Neutral

Williams %R

-40.00

Buy

CCI (14)

47.72

Neutral

ATR (14)

0.01

Ultimate Oscillator

49.83

Neutral

ROC

25.00

Buy

Microba Life Sciences Limited’s (MAP) Relative Strength Index (RSI) is 65.94, creating a Neutral signal.

Microba Life Sciences Limited’s (MAP) Trend Strength Indicator (ADX) is 45.45, creating a Neutral signal.

Microba Life Sciences Limited’s (MAP) Commodity Channel Index (CCI) is 47.72, creating a Neutral signal.

Microba Life Sciences Limited’s (MAP) Price Rate of Change (ROC) is 25.00, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is MAP a Buy, Hold, or Sell?

Based on MAP’s technical indicators, MAP is a Buy.

What is MAP’s RSI (14)?

MAP’s RSI (14) is 65.94, which suggests MAP is a Neutral.

What is MAP’s MACD?

MAP’s MACD is 0.02, which suggests MAP is a Sell.

What is MAP’s 5-day moving average?

MAP’s 5-day moving average is 0.25, which suggests MAP is a Sell.

What is MAP’s 20-day moving average?

MAP 20-day moving average is 0.23, which suggests MAP is a Buy.

What is MAP’s 50-day moving average?

MAP’s 50-day moving average is 0.19, which suggests MAP is a Buy.

What is MAP’s 200-day moving average?

MAP’s 200-day moving average is 0.18, which suggests MAP is a Buy.

What is MAP’s Williams % R (14)?

MAP’s Williams % R (14) is -40.00, which suggests MAP is a Buy.

What is MAP’s CCI (14)?

MAP’s CCI (14) is 47.72, which suggests MAP is a Neutral.

What is the share price of Microba Life Sciences Limited?

Microba Life Sciences Limited's share price is N/AAU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing